93 related articles for article (PubMed ID: 20382523)
21. Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
Lugtenberg RT; Cransberg K; Loos WJ; Wagner A; Alders M; van den Heuvel-Eibrink MM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1039-44. PubMed ID: 18273617
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
23. The 2000 Burkitt lymphoma trial in Malawi.
Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
[TBL] [Abstract][Full Text] [Related]
24. Further experience with laparoscopic nephrectomy for Wilms' tumour after chemotherapy.
Duarte RJ; Dénes FT; Cristofani LM; Odone-Filho V; Srougi M
BJU Int; 2006 Jul; 98(1):155-9. PubMed ID: 16831161
[TBL] [Abstract][Full Text] [Related]
25. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
26. Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Corapcioglu F; Dillioğlugil O; Sarper N; Akansel G; Calişkan M; Arisoy AE
Urology; 2004 Oct; 64(4):807-10. PubMed ID: 15491732
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
28. The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal rupture.
Rutigliano DN; Kayton ML; Steinherz P; Wolden S; La Quaglia MP
J Pediatr Surg; 2007 Sep; 42(9):1595-9. PubMed ID: 17848255
[TBL] [Abstract][Full Text] [Related]
29. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK
Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
[TBL] [Abstract][Full Text] [Related]
31. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
Seseke F; Rebmann S; Zöller G; Lakomek M; Ringert RH
Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
[TBL] [Abstract][Full Text] [Related]
33. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.
Miller AA; Rosner GL; Egorin MJ; Hollis D; Lichtman SM; Ratain MJ
Clin Cancer Res; 2004 Dec; 10(24):8325-31. PubMed ID: 15623609
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
[TBL] [Abstract][Full Text] [Related]
35. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
[TBL] [Abstract][Full Text] [Related]
36. Refining therapeutic strategies for patients with resistant Wilm's tumor.
Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
[TBL] [Abstract][Full Text] [Related]
39. The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study.
Mitchell C; Jones PM; Kelsey A; Vujanic GM; Marsden B; Shannon R; Gornall P; Owens C; Taylor R; Imeson J; Middleton H; Pritchard J
Br J Cancer; 2000 Sep; 83(5):602-8. PubMed ID: 10944599
[TBL] [Abstract][Full Text] [Related]
40. Acquired Von Willebrand disease in children with a Wilms' tumor.
Jonge Poerink-Stockschlader AB; Dekker I; Risseeuw-Appel IM; Hählen K
Med Pediatr Oncol; 1996 Apr; 26(4):238-43. PubMed ID: 8600334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
